International Journal of COPD (May 2024)

Blood miRNAs as Potential Diagnostic Biomarkers for Chronic Obstructive Pulmonary Disease: A Meta-Analysis

  • Li X,
  • Fu G,
  • Zhang C,
  • Wu Y,
  • Guo H,
  • Li W,
  • Zeng X

Journal volume & issue
Vol. Volume 19
pp. 981 – 993

Abstract

Read online

Xiaohua Li,1,* Guoxia Fu,1,* Chunrong Zhang,1,* Yu Wu,2 Hua Guo,1 Weiming Li,1 Xuefeng Zeng1 1Department of Respiratory and Critical Care Medicine, Sixth People’s Hospital of Chengdu, Chengdu, Sichuan, 61005, People’s Republic of China; 2West China School of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China*These authors contributed equally to this workCorrespondence: Weiming Li; Xuefeng Zeng, Department of Respiratory and Critical Care Medicine, Sixth People’s Hospital of Chengdu, No. 16 Jianshe South Street, Chengdu, Sichuan Province, 610051, People’s Republic of China, Email [email protected]; [email protected]: Investigate the efficacy of blood microRNAs (miRNAs) as diagnostic biomarkers for Chronic Obstructive Pulmonary Disease (COPD).Patients and Methods: We conducted a comprehensive search in English and Chinese databases, selecting studies based on predetermined criteria. Diagnostic parameters like summarized sensitivity (SSEN), summarized specificity (SSPE), summarized positive likelihood ratio (SPLR), summarized negative likelihood ratio (SNLR), and diagnostic odds ratio (DOR), and area under the curve (AUC) of the summary receiver operating characteristic (SROC) curves were analyzed using a bivariate model. Each parameter was accompanied by a 95% confidence interval (CI).Results: Eighteen high-quality studies were included. For diagnosing COPD with blood miRNAs, the SSEN was 0.83 (95% CI 0.76– 0.89), SSPE 0.76 (95% CI 0.70– 0.82), SPLR 3.50 (95% CI 2.66– 4.60), SNLR 0.22 (95% CI 0.15– 0.33), DOR 15.72 (95% CI 8.58– 28.77), and AUC 0.86 (95% CI 0.82– 0.88). In acute exacerbations, SSEN was 0.85 (95% CI 0.76– 0.91), SSPE 0.80 (95% CI 0.73– 0.86), SPLR 4.26 (95% CI 3.05– 5.95), SNLR 0.19 (95% CI 0.12– 0.30), DOR 22.29 (95% CI 11.47– 43.33), and AUC 0.89 (95% CI 0.86– 0.91).Conclusion: Blood miRNAs demonstrate significant accuracy in diagnosing COPD, both in general and during acute exacerbations, suggesting their potential as reliable biomarkers.Keywords: miRNAs, chronic obstructive pulmonary disease, biomarker, meta-analysis, diagnosis

Keywords